Shanghai HeartCare Medical Technology Co., Ltd.

HeartCare Medical (Stock Code: 06609.HK), established in 2016, is a leading neuro-interventional medical device company offering one-stop solutions for stroke treatment and prevention. Our main directions include neuro-hemorrhagic and neuro-ischemic treatments — both acute and chronic — as well as access solutions and ischemic prevention.

We have experienced rapid growth and sucessfully listed on the HK Stock market within just 5 years. Our product portfolio includes over 30 quality products that serve the expanding neurovascular market, with an additional 20 products planned for launch in the next 3 years.

To support global innovation and manufacturing, HeartCare operates 3 R&D centers located in Irvine USA, Shanghai, and Nanjing cooperates with 2 production facilities in Shanghai and Nanjing.